ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 235 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $899,867 | +409.4% | 71,418 | +427.6% | 0.13% | +392.6% |
Q1 2023 | $176,658 | +11.1% | 13,537 | +25.9% | 0.03% | +80.0% |
Q2 2022 | $159,000 | -40.7% | 10,752 | -9.6% | 0.02% | -31.8% |
Q1 2022 | $268,000 | -65.1% | 11,899 | -71.4% | 0.02% | -71.8% |
Q4 2021 | $768,000 | +74.9% | 41,601 | +75.2% | 0.08% | +62.5% |
Q2 2021 | $439,000 | +156.7% | 23,740 | +36.5% | 0.05% | +108.7% |
Q4 2019 | $171,000 | – | 17,395 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |